Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
Hepatitis C virus (HCV) enters cells via interactions with several host factors, a key one being that between the viral E2 envelope glycoprotein and the CD81 receptor. We previously identified E2 tryptophan residue 420 (W420) as an essential CD81-binding residue. However, the importance of W420 in the context of the native virion is unknown, as those previous studies predate the infectious HCV cell culture (cell culture-derived HCV [HCVcc]) system. Here, we introduced four separate mutations (F, Y, A, or R) at position 420 within the infectious HCVcc JFH-1 genome and characterized their effects on the viral life cycle. While all mutations reduced E2-CD81 binding, only two (W420A and W420R) reduced HCVcc infectivity. Further analyses of mutants with hydrophobic residues (F or Y) found that interactions with the receptors SR-BI and CD81 were modulated, which in turn determined the viral uptake route. Both mutant viruses were significantly less dependent on SR-BI, and its lipid transfer activity, for virus entry. Furthermore, these viruses were resistant to the drug erlotinib, which targets epidermal growth factor receptor (EGFR) (a host cofactor for HCV entry) and also blocks SR-BI-dependent high-density lipoprotein (HDL)-mediated enhancement of virus entry. Together, our data indicate a model where an alteration at position 420 causes a subtle change in the E2 conformation that prevents interaction with SR-BI and increases accessibility to the CD81-binding site, in turn favoring a particular internalization route. These results further show that a hydrophobic residue with a strong preference for tryptophan at position 420 is important, both functionally and structurally, to provide an additional hydrophobic anchor to stabilize the E2-CD81 interaction.



Hepatitis C virus (HCV) is a leading cause of liver disease, causing up to 500,000 deaths annually. The first step in the viral life cycle is the entry process. This study investigates the role of a highly conserved residue, tryptophan residue 420, of the viral glycoprotein E2 in this process. We analyzed the effect of changing this residue in the virus and confirmed that this region is important for binding to the CD81 receptor. Furthermore, alteration of this residue modulated interactions with the SR-BI receptor, and changes to these key interactions were found to affect the virus internalization route involving the host cofactor EGFR. Our results also show that the nature of the amino acid at this position is important functionally and structurally to provide an anchor point to stabilize the E2-CD81 interaction.
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Vanessa M
VM
Cowton
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Allan G N
AGN
Angus
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Sarah J
SJ
Cole
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Christina K
CK
Markopoulou
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Ania
A
Owsianka
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
James I
JI
Dunlop
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom.
Deborah E
DE
Gardner
Institut Pasteur, Unité de Virologie Structurale, Department Virologie, Paris, France.|CNRS UMR 3569, Paris, France.|Institute of Virology, Hannover Medical School, Hannover, Germany.|German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany.
Thomas
T
Krey
MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Glasgow, United Kingdom arvind.patel@glasgow.ac.uk.
Arvind H
AH
Patel
D019943:Amino Acid Substitution; D000596:Amino Acids / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D004252:DNA Mutational Analysis; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D016297:Mutagenesis, Site-Directed; D051122:Scavenger Receptors, Class B / Q000378:metabolism; D060225:Tetraspanin 28 / Q000378:metabolism; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D053585:Virus Attachment; D053586:Virus Internalization
D000596:Amino Acids; C554798:CD81 protein, human; C495124:SCARB1 protein, human; D051122:Scavenger Receptors, Class B; D060225:Tetraspanin 28; D014759:Viral Envelope Proteins; C091015:glycoprotein E2, Hepatitis C virus